INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
IH
Irby John H.Director
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
21.9K sh
Jan 1, 2026Jan 2, 2026
Page 1548 of 1814
← PrevNext →
traded Jan 1, 2026
+1d
SEC Form 4

Evidence

9
BZ
Bishop Daniel ZacharyEVP, Tech., Ops., & Sec.
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
10.5K sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Option exercise
M—
13 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
WM
Wise James MichaelSVP & Chief Accounting Officer
VYXNCR Voyix Corp
Option exercise
M—
1,735 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
SE
Smith Mary EllenDirector
KAROPENLANE, Inc.
Grant or award
A$23K
777 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
AS
Apter StacyDirector
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
11.4K sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
DJ
Drew Christopher JDirector
CTOCTO Realty Growth, Inc.
Grant or award
A$16K
901 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

9
WK
Weislogel KatherineEVP & Exec. Dir., Treasury
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
32.4K sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
DD
Delamater William DanielEVP & Chief Oper Officer
DGICADONEGAL GROUP INC
Grant or award
A—
3,600 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
BZ
Bishop Daniel ZacharyEVP, Tech., Ops., & Sec.
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
43.5K sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
GV
Gupta VikasChief Investment Officer
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
11.6K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
BD
Bacon DebraEVP, Medicaid
MOHMOLINA HEALTHCARE, INC.
Grant or award
A$3,245
22 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
DT
Dierdorff Thomas TEVP, Corp. & Inv. Banking
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
5,961 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
WM
Winter Charles M.Chief Technical Officer
JANXJanux Therapeutics, Inc.
Grant or award
A—
100.1K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

9
DT
DiRaimondo ThomasChief Scientific Officer
JANXJanux Therapeutics, Inc.
Grant or award
A—
109.9K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

9
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Option exercise
M—
71 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
ML
Mataac LaraGeneral Counsel
OSPNOneSpan Inc.
Tax withholding
F$13K
1,003 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
GS
Goodwine SharonEVP Chief Human Resources Off
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
5,395 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
HS
Hammock SamanthaEVP & Chief HR Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$989
85 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
JL
Jones Bryn LlywelynDirector
FEAM5E Advanced Materials, Inc.
Grant or award
A—
5,118 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
IH
Irby John H.Director
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
9,885 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
MZ
McIver ZachariahChief Medical Officer
JANXJanux Therapeutics, Inc.
Grant or award
A—
101.5K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

9
ML
Mataac LaraGeneral Counsel
OSPNOneSpan Inc.
Option exercise
M—
8,492 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
AS
Altshuler Kristi SpencerSr. Vice President
DGICADONEGAL GROUP INC
Grant or award
A—
3,000 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
GM
Gordon Susan M.Director
BKSYBlackSky Technology Inc.
Grant or award
A—
1,200 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
MK
McAleenan KevinDirector, Chief Executive Officer
BBAIBigBear.ai Holdings, Inc.
Tax withholding
F$26K
4,663 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
GV
Gupta VikasChief Investment Officer
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
15.4K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
GV
Gupta VikasChief Investment Officer
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
12.0K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
BZ
Bishop Daniel ZacharyEVP, Tech., Ops., & Sec.
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
9,322 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Grant or award
A—
338.1K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

9
DT
Dierdorff Thomas TEVP, Corp. & Inv. Banking
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
9,159 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Option exercise
M—
5,695 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
DN
Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr
JANXJanux Therapeutics, Inc.
Grant or award
A—
126.0K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

9
ML
Mataac LaraGeneral Counsel
OSPNOneSpan Inc.
Tax withholding
F$32K
2,493 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
SW
Sponic David WayneSenior Vice President
DGICADONEGAL GROUP INC
Grant or award
A—
3,000 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
DB
Dick BarryDirector
FEAM5E Advanced Materials, Inc.
Grant or award
A—
5,970 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
CS
Creson ShellieEVP and Chief Risk Officer
SNVSYNOVUS FINANCIAL CORP
Disposition to issuer
D—
7,536 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
MM
Morral Peter M.Chief Development Officer
GPMTGranite Point Mortgage Trust Inc.
Option exercise
M—
60.1K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$2,571
418 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence

9
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Grant or award
A$6,209
173 sh
Jan 1, 2026Jan 2, 2026
traded Jan 1, 2026
+1dSEC Form 4

Evidence